PEOPLE - Helicos BioSciences makes appointment:
This article was originally published in Clinica
Lifescience company Helicos BioSciences (Cambridge, Massachusetts) has announced interim appointments in response to the resignation of Louise Mawhinney, senior vice-president and CFO. President and COO Steve Lombardi will step in as principal financial officer, while Kevin Lafond, the firm's controller, will stand in as principal accounting officer. Ms Mawhinney has left the firm to pursue other interests. Helicos' proprietary genetic analysis technology is designed to be used across the diagnostics, research and drug discovery markets.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.